Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AveXis’ Zolgensma Aproved for Pediatric Patients with Spinal Muscular Atrophy

contractpharmaJune 14, 2019

Tag: AveXis , Zolgensma , spinal , Muscular , sma

PharmaSources Customer Service